Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Celgene Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Active Multiple Myeloma Stage II or III Durie Salmon
Measurable levels of myeloma paraprotein in serum (≥1.0g/dL) or urine (≥ 0.2g excreted in a 24-hour collection sample)
Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2
Women of child bearing potential must agree to abstain for heterosexual intercourse or use 2 methods of contraception, one effective (for example hormonal or tubal ligation) and one barrier (for example latex condom, diaphragm)
Males must agree to use barrier contraception (latex condoms) when engaging in reproductive activity
You may not be if
Pregnant or lactating females
Peripheral neuropathy ≥ to grade 2 of the NCI CTC.
Prior history of malignancy unless subject has been free of disease for ≥ 3 years
Lab abnormality: Serum glutamic oxaloacetic transaminase (SGOT) /Aspartate aminotransferase (AST) or Serum glutamic pyruvic transaminase (SGPT)/Alanine transaminase (ALT) \>3.0 x upper limit of normal (ULN)
Lab abnormality: Serum total bilirubin \> 2.0 mg/dL (34 µmol/L)
Clareo Health | A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
